<DOC>
	<DOCNO>NCT00264446</DOCNO>
	<brief_summary>5 fluorouracil ( 5 FU ) , one actively investigate anti-cancer drug , rapidly inactivate enzyme dihydropyrimidine dehydrogenase ( DPD ) . ADH300004 block DPD . This study examine kinetics inhibition recovery metabolic pathways fluoropyrimidines subject receive single oral dose ADH300004 , may allow optimization oral 5 FU dose subject future study .</brief_summary>
	<brief_title>A Study ADH300004 Surgically Resected Primary Metastatic Colorectal Cancer Liver Biopsy , Planned Hepatic Resection</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Eniluracil</mesh_term>
	<criteria>Signed write informed consent &gt; = 19 year age Patients histologically confirm : primary metastatic ( know suspect ) colorectal carcinoma require plan surgical resection hepatic biopsy systemic chemotherapy , primary metastatic neoplastic disease within liver origin require plan surgical resection systemic chemotherapy Adequate performance status organ function , evidence hematological biochemical blood test Lack know suspect metastatic disease liver Known DPD deficiency Severe infection Inability take oral medication The need treatment fluoropyrimidine within 8 week ADH300004 dose Stroke , major surgery , major tissue injury within 30 day study entry</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Cancer ; Tumors ; Neoplasms ; Anticarcinogenic Agents ; Antineoplastic Agents ;</keyword>
	<keyword>Dihydrouracil dehydrogenase ( NADP ) ; Colorectal Carcinoma ; Liver Cancer</keyword>
</DOC>